Published in
Wiley Open Access, Cancer Medicine, 14(9), p. 4991-5007, 2020
DOI: 10.1002/cam4.3131
Links
Tools
Sorafenib and everolimus in patients with advanced solid tumors and KRAS-mutated NSCLC: A phase I trial with early pharmacodynamic FDG-PET assessment
Journal article published in 2020 by
Lucia Nogova 
,
Christian Mattonet,
Matthias Scheffler ,
Max Taubert,
Masyar Gardizi,
Martin L. Sos ,
Sebastian Michels,
Rieke N. Fischer,
Meike Limburg,
Diana S. Y. Abdulla,
Thorsten Persigehl,
Carsten Kobe,
Sabine Merkelbach-Bruse,
Jeremy Franklin,
Heiko Backes
and other authors.
,
Christian Mattonet,
Matthias Scheffler ,
Max Taubert,
Masyar Gardizi,
Martin L. Sos ,
Sebastian Michels,
Rieke N. Fischer,
Meike Limburg,
Diana S. Y. Abdulla,
Thorsten Persigehl,
Carsten Kobe,
Sabine Merkelbach-Bruse,
Jeremy Franklin,
Heiko Backes
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 